Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Nephrotic Syndrome II : Assessment and Medical Management01:26

Nephrotic Syndrome II : Assessment and Medical Management

192
IntroductionNephrotic syndrome is a kidney disorder marked by excessive protein loss in the urine, leading to various systemic complications. This condition often results from damage to the glomeruli—the kidney's filtering units—causing proteinuria, low blood protein levels, and fluid retention. Understanding the assessment, diagnosis, and management of nephrotic syndrome is essential for effective treatment and prevention of further kidney damage.AssessmentPatient History: Document...
192
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

531
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
531
Nephrotic Syndrome I : Introduction01:24

Nephrotic Syndrome I : Introduction

488
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
488
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

256
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
256
Nephrotic Syndrome III : Nursing Management01:24

Nephrotic Syndrome III : Nursing Management

277
Nursing management for nephrotic syndrome adapts as the disease progresses, with strategies evolving to address advancing symptoms and complications.Early-Stage Management In the early stages, nursing interventions for nephrotic syndrome resemble those used in managing acute glomerulonephritis, focusing on symptom monitoring, fluid balance, and managing mild to moderate edema.Vital Signs: Regularly monitor blood pressure, pulse, respiratory rate, and temperature to promptly identify...
277
Serum Studies: Renal Function Tests01:24

Serum Studies: Renal Function Tests

359
Renal function tests are crucial for assessing kidney health, monitoring disease progression, and evaluating the kidneys' efficiency in waste elimination, fluid balance, and electrolyte regulation. These tests offer critical insights into kidney function, even though routine measurements may appear normal until there is a significant decline in the glomerular filtration rate or GFR. Typically, signs of kidney impairment only become evident when the GFR falls to about 50% of its normal level.
359

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Phenotypic Variability of Kidney Involvement in Fabry Disease-Lessons from a Family Study.

Life (Basel, Switzerland)·2026
Same author

Long-term outcomes and prognosis of mixed cryoglobulinaemia: a European multicentre study of 1294 patients.

Rheumatology (Oxford, England)·2026
Same author

Kidney imaging for the diagnosis and follow-up of a primary hyperoxaluria type 1 patient with NC, NL, and severe chronic kidney disease: a case report with literature review.

Medical ultrasonography·2026
Same author

Prognostic Stratification in Primary Glomerulonephritis: Integrating Histology, Biomarkers, and Risk Prediction Models.

Life (Basel, Switzerland)·2026
Same author

Correction: Terminal complement inhibition in atypical haemolytic uremic syndrome: a single-centre experience.

Frontiers in pharmacology·2025
Same author

Incidence, Risk Factors, and Clinical Outcomes of Active Tuberculosis in Kidney Transplant Recipients From Romania: A Single-Center Study.

Transplant infectious disease : an official journal of the Transplantation Society·2025

Related Experiment Video

Updated: Jan 13, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.4K

Biomarkers in Lupus Nephritis: An Evidence-Based Comprehensive Review.

Alexandra Vrabie1, Bogdan Obrișcă1,2, Bogdan Marian Sorohan1,3

  • 1Department of Nephrology, "Carol Davila" University of Medicine and Pharmacy, 050474 Bucharest, Romania.

Life (Basel, Switzerland)
|October 29, 2025
PubMed
Summary
This summary is machine-generated.

Lupus nephritis (LN) diagnosis still relies on traditional biomarkers like anti-dsDNA and proteinuria. While novel biomarkers show promise, none have replaced current methods, highlighting the need for further validation in clinical practice.

Keywords:
biomarkersdiagnosislupus nephritismonitoringprognosisrenal flaresystemic lupus erythematosus

More Related Videos

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.5K
Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

12

Related Experiment Videos

Last Updated: Jan 13, 2026

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice
09:43

Analyses of Proteinuria, Renal Infiltration of Leukocytes, and Renal Deposition of Proteins in Lupus-prone MRL/lpr Mice

Published on: June 8, 2022

3.4K
The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice
12:04

The bm12 Inducible Model of Systemic Lupus Erythematosus SLE in C57BL/6 Mice

Published on: November 1, 2015

18.5K
Murine Bilateral Renal Lymphadenectomy
06:20

Murine Bilateral Renal Lymphadenectomy

Published on: December 30, 2025

12

Area of Science:

  • Nephrology
  • Immunology
  • Biomarker Discovery

Background:

  • Lupus nephritis (LN) significantly impacts patient mortality and morbidity.
  • Biomarkers are crucial for less invasive LN evaluation and personalized medicine.

Purpose of the Study:

  • To review studies on urinary and serological biomarkers for LN diagnosis, activity, treatment response, and renal outcomes.
  • To summarize findings from the past decade, emphasizing traditional tools.

Main Methods:

  • Systematic review of published studies over the last ten years.
  • Focus on urinary and serological biomarkers in adult patients with LN.
  • Emphasis on comparison with traditional diagnostic and monitoring tools.

Main Results:

  • Traditional biomarkers include proteinuria, urinary sediment, eGFR, anti-dsDNA, anti-C1q, and complement levels.
  • Anti-dsDNA, C3, and proteinuria are conventional biomarkers with moderate predictive ability.
  • Novel biomarkers like ALCAM, CD163, CXCL10, MCP-1, NGAL, TWEAK, and VCAM-1 show potential but require validation.

Conclusions:

  • No novel biomarkers have replaced traditional ones in clinical practice for LN assessment.
  • Further validation of novel biomarkers in independent cohorts and integration with histology are necessary.
  • Current management of LN still relies on established biomarkers for non-invasive assessment and treatment guidance.